NCT06191185 2026-03-11
IMPACTT
University of California, San Francisco
Phase NA Enrolling by invitation
Clinical Trials
75 trialsNCT06506955 2026-03-11
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Taiho Oncology, Inc.
Phase 2/3 Enrolling by invitation
NCT07441369 2026-03-02
Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer
Fudan University
Phase 2 Enrolling by invitation
NCT07429760 2026-02-24
Mechanical Bowel Preparation With or Without Oral Antibiotics in Left Sided Colorectal Cancer Surgery
Shaukat Khanum Memorial Cancer Hospital & Research Centre
Phase NA Enrolling by invitation
NCT07116668 2026-02-18
SAFE-3CV
SafeHeal Inc
Phase NA Enrolling by invitation
NCT06184594 2026-02-17
Evaluating the Efficacy of the eNav Toolkit to Improve Colorectal Cancer Screening
Icahn School of Medicine at Mount Sinai
Phase NA Enrolling by invitation
NCT06822530 2026-02-17
A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
Fred Hutchinson Cancer Center
Phase NA Enrolling by invitation
NCT07386704 2026-02-04
Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer
Peking University First Hospital
Phase 2 Enrolling by invitation
NCT07381985 2026-02-02
LINC
University of Vermont Medical Center
Phase NA Enrolling by invitation
NCT07376980 2026-01-29
MST
Korea University Anam Hospital
Phase NA Enrolling by invitation
NCT07371247 2026-01-27
Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1 Enrolling by invitation
NCT05443321 2026-01-23
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Brigham and Women's Hospital
Phase NA Enrolling by invitation
NCT07347158 2026-01-16
Effectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiety and Depression in Ostomy Patients Following Digestive Surgery: A Quasi-Experimental Study.
Hospital Clinico Universitario de Santiago
Phase NA Enrolling by invitation
NCT06603519 2026-01-15
Impact of Dietary Intervention on Inflammation and Microbiome Composition Post-Colonoscopy
University of California, San Diego
Phase NA Enrolling by invitation
NCT07344220 2026-01-15
DZ-002-201
Hoag Memorial Hospital Presbyterian
Phase 2 Enrolling by invitation
NCT07334587 2026-01-12
Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma
Allama Iqbal Medical College
Phase NA Enrolling by invitation
NCT07106359 2026-01-07
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
University of Alabama at Birmingham
Phase NA Enrolling by invitation
NCT07139951 2025-12-31
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Patients With Gastric and Gastroesophageal Junction Adenocarcinoma at High Risk of Peritoneal Recurrence
Mayo Clinic
Phase 2 Enrolling by invitation
NCT07312578 2025-12-31
Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma
Peking University
Phase 2 Enrolling by invitation
NCT07310069 2025-12-30
TRANSFORM-GBC
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Enrolling by invitation
NCT07050485 2025-12-29
Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery
University of South Florida
Phase NA Enrolling by invitation
NCT06744595 2025-12-12
Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer
Mayo Clinic
Phase NA Enrolling by invitation
NCT06603987 2025-11-19
Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA
Stella Pharma Corporation
Phase 1/2 Enrolling by invitation
NCT07230795 2025-11-17
AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake
Abramson Cancer Center at Penn Medicine
Phase NA Enrolling by invitation
NCT04561791 2025-10-22
Evaluation of Tethered Capsule Endomicroscopy as a Screening Tool for Barrett's Esophagus in the Primary Care Setting
Massachusetts General Hospital
Phase NA Enrolling by invitation
NCT06401174 2025-10-22
SCREEN
Medstar Health Research Institute
Phase NA Enrolling by invitation
NCT06230965 2025-10-01
Clinical Study of Lung Protective Ventilation Strategies and Tumor Microenvironment
Affiliated Hospital of Nantong University
Phase NA Enrolling by invitation
NCT06636864 2025-09-25
Effect of Intrathecal Morphine on Quality of Recovery After Laparoscopic Colorectal Cancer Surgery
Sun Yat-sen University
Phase NA Enrolling by invitation
NCT06882876 2025-09-19
JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study
Xiangya Hospital of Central South University
Phase 1 Enrolling by invitation
NCT06085560 2025-09-16
Choose It and Use It: Choice, Implementation Intentions and At-Home Colorectal Cancer Screening
Michigan State University
Phase NA Enrolling by invitation
NCT04246970 2025-09-15
PreLiveR-T
Hospital Universitario La Fe
Phase NA Enrolling by invitation
NCT06931860 2025-09-09
Head to Head Trial of Mailed Cologuard to Mailed FIT
University of California, San Diego
Phase NA Enrolling by invitation
NCT06228209 2025-09-04
TIER-PC
Icahn School of Medicine at Mount Sinai
Phase NA Enrolling by invitation
NCT06936527 2025-09-03
XS-03-II201
NovaOnco Therapeutics Co., Ltd.
Phase 1/2 Enrolling by invitation
NCT05385861 2025-08-15
Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET
National Health Research Institutes, Taiwan
Phase 1/2 Enrolling by invitation
NCT03550885 2025-08-13
Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk
University of Illinois at Chicago
Phase NA Enrolling by invitation
NCT06914726 2025-08-05
PC-CDS
HealthPartners Institute
Phase NA Enrolling by invitation
NCT07046832 2025-07-02
Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy
MediView XR, Inc.
Phase NA Enrolling by invitation
NCT07023848 2025-06-17
PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07023861 2025-06-17
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07016737 2025-06-12
ESO-Nanjing12
Jiangsu Cancer Institute & Hospital
Phase 3 Enrolling by invitation
NCT06990178 2025-05-25
Adaptive Neoadjuvant Therapy for Esophageal Cancer
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Phase NA Enrolling by invitation
NCT06855355 2025-05-16
CBM588 Reduces Colorectal Polyp Recurrence
Kaohsiung Medical University
Phase NA Enrolling by invitation
NCT06967662 2025-05-16
INTRACOR_pilot
Ilyinskaya Hospital, JSC
Phase NA Enrolling by invitation
NCT06963060 2025-05-08
GALENT-BT
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Enrolling by invitation
NCT06929481 2025-05-02
Screening With a DNA Blood Test to Address Colorectal Cancer Inequities
University of California, San Diego
Phase NA Enrolling by invitation
NCT06936488 2025-04-20
A Prospective, Single Arm, Open Label, Phase II Clinical Study on the Efficacy and Safety of Ivonescimab (AK112) Combined With TAS-102 in the Treatment of Refractory MSS/pMMR Advanced Colorectal Cancer
Huai'an First People's Hospital
Phase NA Enrolling by invitation
NCT06931808 2025-04-17
Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer
First Affiliated Hospital of Ningbo University
Phase 4 Enrolling by invitation
NCT05706025 2025-04-06
Study to Evaluate EnteroTracker® as a Sampling Method to Screen for Barrett's Esophagus/Esophageal Cancer
University of Colorado, Denver
Phase NA Enrolling by invitation
NCT06223022 2025-04-02
Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment
Umeå University
Phase NA Enrolling by invitation